[ad_1]
Medical technology and pharmaceutical companies are moving beyond biopharmaceuticals, medical devices, and equipment to provide comprehensive patient care. The key is to provide and manage proactive, predictive and personalized care that is sustainable. This will enable better outcomes, improve the experience of patients and clinicians in care pathways, reduce health care costs, eliminate inefficiencies in workflows, and maximize capacity convergence.
To provide importance and distinction, many medical technology and pharmaceutical companies have embraced digitalization. Digitalization is now seen as the driving force behind this transition, as healthcare companies strive to improve value for their customers and partners.
With the availability of digital tools and technologies, the industry aims to accelerate the use of health data for process improvement, product development and value proposition by exploring new models for making money.
Succeeding in digital transformation
Medical technology companies have always had to choose where to invest their research and development resources: when they prioritize the development of basic skills and solutions, or when it comes to digital infrastructure and analytical capabilities. While both are essential, not all companies have the funds to do both or to develop skills in algorithms for managing or analyzing data sets, or to leverage partner ecosystem risk, collaborate, create, and share. In addition, these companies may not have the experience to use clinical data to establish governance and compliance structures in compliance with regulations.
Specific internal capabilities, as well as planning and resources are needed to develop and maintain the digital ecosystem to reap the many benefits of data, analytics, and partnerships with the right partners. The platforms provide a cloud-based ecosystem for secure access and data sharing between multiple stakeholders, enabled by digital tools and applications, while providing a way for companies with similar ideas to collaborate.
Thus, the platform as a service (PaaS) allows users to take advantage of subscription-based data and cloud computing service without the complexity of building and maintaining infrastructure. It allows users to access, develop and run applications and unify digital transformation using a single platform, reducing the use of resources needed to drive transformation.
“The data is in the silos, and to optimize clinical pathways, all actors need to work together to create and work together,” says Max Milz, senior partner and senior vice president at Siemens Advanta Consulting. “In other words, data needs to be accessed, processed, stored, analyzed and shared in a secure and unified way to be useful to different stakeholders. PaaS is one of the enablers to drive this integration. Medical technology companies can accelerate digital transformation efforts to access the data provided by the last mile group digital gaming health platforms. “
Medical technology needs a specific platform
Most use cases for health data management are industry-dependent, requiring access to imaging, pathology, and clinical data. Stakeholders considering a platform would collaborate with someone who is domain specific, and be incubated and managed by another experienced medical technology organization.
A medical technology platform provides vertical domain knowledge for market access and connectivity to provide relevant data, industry-specific applications, and experience with partners on safety and regulatory compliance requirements to focus on developing core solutions. and value propositions. Using medical technology, PaaS provides medical equipment and devices with the flexibility to continuously adapt to market needs by optimizing investments in time and resources, guided by a valued partner with experience in developing a platform that serves this purpose.
In a competitive market, medical technology companies need to focus on rapid product development by partnering with the best PaaS provider to help achieve the overall goals of digital transformation.
“Most medical technology companies have a strong presence of products,” explains Thomas Friese, senior vice president of digital platforms at Siemens Healthineers. “However, what they need is to transform into a sustainable service model.”
And there’s no need to go it alone. “Cooperation is gaining prominence in the field of medical technology and pharmacy, and all actors benefit only from integration. PaaS will be very important in this context, thus positioning a digital team health platform in a unique way with specialization and transformation of its specific domains with digital capabilities, ”says Friese.
A Proven and compatible PaaS platform: team play
The company, which has extensive experience in imaging and diagnostics, can build a platform that includes robust basic diagnostics and therapeutic therapy and specialized digital offerings, and can be systematically expanded into multiple functionalities.
Various use cases can be used as a template for technology advancement to help partners achieve their goals. team play acts as an accelerator for tech companies, providing first-mile connectivity and last-mile access.
As a platform provider of specific medical technology, Siemens Healthineers offers vertical domain specialization and industry specialization, distinguishing it from the capabilities of horizontal platforms offered by leading IT companies. The subscription model allows users to expand their investment over time and create higher returns by giving partners a head start. Overall, Siemens Healthineers has a clear vision of where it fits in, increasing loyalty and ease of use with partners, while reducing time and effort for its partners.
The partnership offers the benefits of digital transformation
The advantages of collaborating to create PaaS are obvious: it is a more strategic and long-term opportunity to collaborate, create together, and share risk. Compared to building the platform, collaboration provides scalability by optimizing time, resources, and investments. While building a platform with a cloud public service provider, medical technology companies still need to network with hospitals to access data and arrange for integration with devices and the healthcare IT ecosystem.
Collaborating with PaaS medical technology, however, provides scalability in terms of access and connectivity, and the platform offers the ability to evolve by introducing new products, applications, and vendors.
Medical technology companies need to choose a partner that matches the vision, breadth, and service of the overall digital transformation effort. The partnership with Siemens Healthineers provides access to a proven platform that is compatible, safe and acts as a technology accelerator. It also offers the potential to focus on core competencies while collaborating to explore new and side-by-side opportunities.
The team digital health platform connects and integrates data from all sources and organizations across multiple departments and organizations into a vendor, system, and device-neutral platform. It provides scalable deployment models with hybrid computing, combining cloud and borderline deployment to serve specific use cases. Access is open to AI and digital health innovations and solutions with opportunities for Siemens Healthineers and its partner network commissioners to collaborate with peers and partners that enable risk-sharing models. It enables the deployment and operation of applications and algorithms using a secure platform infrastructure around the world.
Most importantly, with Siemens Healthineers, medical technology companies have the opportunity to collaborate on a platform that is constantly evolving and offers clinical credibility and business relevance.
Learn more PaaS technology in health care.
This content was created by Insights, a custom content from the MIT Technology Review. It was not written in the editorial board of the MIT Technology Review.
[ad_2]
Source link
